Figure 1 - CSAMT Survey Lines on TMI
Evergold – CSAMT Survey Over DEM1 Prospect, B.C., Reveals Large Target Extending Across All Lines and to Depth Below Reconnaissance Drill Holes
13 mai 2024 07h00 HE | Evergold Corp.
CSAMT Survey Over Evergold's DEM1 Prospect, B.C., Reveals Large Target Extending Across All Lines and to Depth Below Reconnaissance Drill Holes
HVW Logo.png
Hi-View Appoints Terry Krepiakevich as Board Advisor
13 mai 2024 03h01 HE | Hi-View Resources Inc.
VANCOUVER, British Columbia, May 13, 2024 (GLOBE NEWSWIRE) -- Hi-View Resources Inc. (‘Hi-View' or the ‘Company’) (CSE: HVW; OTCQB: HVWRF; FSE: B63) is pleased to announce that Mr. Terry...
SchooLinks Recognize
SchooLinks Recognized Among America's Best Startup Employers by Forbes and Inc.
08 mai 2024 07h15 HE | SchooLinks
Austin, TX, May 08, 2024 (GLOBE NEWSWIRE) -- SchooLinks, the most innovative platform for college and career readiness, is proud to announce its recent achievements in both business growth and...
QuisLex-Logo-NEW.jpg
QuisLex Incorporates ContractPodAi’s Leah Generative AI Platform into Its Workflows
30 avr. 2024 11h00 HE | QuisLex
NEW YORK, April 30, 2024 (GLOBE NEWSWIRE) -- QuisLex, a leading alternative legal services provider long recognized as a pioneer in the industry, announced today its expanded partnership with...
LPR_Logo_K.png
London Research & Pharmaceuticals presents the advancement of LRP-661, their oral cannabidiol sulphate drug candidate at the prestigious Epilepsy Therapies & Diagnostics Development (ETDD) XVII conference in Miami
15 avr. 2024 08h00 HE | London Research and Pharmaceuticals
London Research & Pharmaceuticals Corp. Presents the Advancement of their Oral Cannabidiol Sulphate Drug Candidate at Epilepsy Therapies Conference
Adyn_MainLogo_Digital_Green.png
Inc.’s 2024 Female Founders list highlights why female founders are always a good bet
09 avr. 2024 12h19 HE | Adyn, Inc.
Inc’s 2024 Female Founders list highlights why female founders are always a good bet. adyn founder, Elizabeth Ruzzo, is named to the list.
OBT-RGB_1417_544 (2).jpg
Oxford BioTherapeutics Announces Launch of Enhanced Discovery Platform, OGAP®-Verify, at World ADC Conference 2024
07 mars 2024 04h00 HE | Oxford BioTherapeutics
OGAP®-Verify allows for significantly enhanced sensitivity and specificity for improved target selection, dramatically accelerating drug target discoveryOGAP-Verify is now more sensitive than...
STELMINE.png
Stelmine planifie une première campagne d’exploration sur ses propriétés du nord du district de Caniapiscau
04 mars 2024 09h55 HE | Stelmine Canada ltée
QUÉBEC, 04 mars 2024 (GLOBE NEWSWIRE) -- Stelmine Canada (“Stelmine” ou “la Société”) (TSXV: STH ). Stelmine planifie actuellement les campagnes de travaux de la saison estivale 2024.Cette...
STELMINE.png
Stelmine is planning a maiden exploration campaign on its northern Caniapiscau properties
04 mars 2024 09h55 HE | Stelmine Canada Ltd.
QUÉBEC CITY, March 04, 2024 (GLOBE NEWSWIRE) -- Stelmine Canada (“Stelmine” or “the Company”) (TSXV: STH). Stelmine is currently planning its summer 2024 work program. This year, a first...
Figure 1
SAGA Metals Announces Intent for Uranium IPO and Provides Corporate Update
22 févr. 2024 09h00 HE | Saga Metals Corp.
Three projects in North America focused on the critical minerals of Uranium, Lithium, Vanadium & Titanium to support the global green energy transition.